Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
Status
Conditions
Details and patient eligibility
About
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes.
The specific aims of this study are to:
- Review whether cephalosporin-resistant E. coli infections are hospital-acquired, healthcare-associated or community-associated.
- Determine the clinical outcome of the patients according to the antibiotics given.
Full description
De-identified data will be obtained by the honest broker for the requested time period. In addtion, the honest broker will work with the microbiology laboratory to collect the isolates associated with the de-identified data. All data and samples will be de-identified. De-identified data will be given to the nurse coordinator to complete the case report forms and enter the data into the password protected database and the de-identified isolates will be stored and analyzed on the 8th floor Scaife in Dr. Yohie Doi's laboratory.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- patients with E. coli infections at UPMC
Exclusion criteria
- not meeting entry criteria
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal